Literature DB >> 2624476

Type II hyperprolinaemia in a pedigree of Irish travellers (nomads).

M P Flynn1, M C Martin, P T Moore, J A Stafford, G A Fleming, J M Phang.   

Abstract

We describe a study of 312 subjects in 71 families near related to a proband with type II hyperprolinaemia. The subjects were Irish travellers (nomads) among whom consanguineous marriage and high fertility are common. Thirteen additional cases of type II hyperprolinaemia were discovered; all were offspring of consanguineous unions. A further 50 subjects were found to have mild hyperprolinaemia. We found a strong association between type II hyperprolinaemia and seizures during childhood but no significant association with mental handicap. Most adults with type II hyperprolinaemia enjoyed normal health and there was no evidence that maternal hyperprolinaemia compromised fetal development. The documented association between type II hyperprolinaemia and seizures may be related to the neuromodulatory or reducing-oxidising effects of proline and pyrroline-5-carboxylate, respectively, that has been shown in vitro. Alternatively, another genetic defect closely linked to the type II hyperprolinaemia allele could be the explanation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2624476      PMCID: PMC1792896          DOI: 10.1136/adc.64.12.1699

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  23 in total

1.  Asymptomatic type II hyperprolinaemia associated with hyperglycinaemia in three sibs.

Authors:  L Pavone; F Mollica; H L Levy
Journal:  Arch Dis Child       Date:  1975-08       Impact factor: 3.791

2.  ION EXCHANGE CHROMATOGRAPHY OF THE FREE AMINO ACIDS IN THE PLASMA OF THE NEWBORN INFANT.

Authors:  J C DICKINSON; H ROSENBLUM; P B HAMILTON
Journal:  Pediatrics       Date:  1965-07       Impact factor: 7.124

3.  Hyperprolinaemia: a disease which does not need treatment?

Authors:  F Mollica; L Pavone
Journal:  Acta Paediatr Scand       Date:  1976-03

4.  Iontophoretic and autoradiographic studies on the role of proline in nervous transmission.

Authors:  D Felix; H Künzle
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

5.  Maternal hyperprolinaemia.

Authors:  D T Whelan; W T Conner
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

6.  Pure familial hyperprolinemia: isolated inborn error of aminoacid metabolism without other anomalies in a Sicilian family.

Authors:  F Mollica; L Pavone; I Antener
Journal:  Pediatrics       Date:  1971-08       Impact factor: 7.124

7.  Hyperprolinemia without renal disease.

Authors:  S Similä; J K Visakorpi
Journal:  Acta Paediatr Scand       Date:  1967

Review 8.  Metabolism of proline and the hydroxyprolines.

Authors:  E Adams; L Frank
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

9.  Type II hyperprolinemia. Delta1-pyrroline-5-carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes.

Authors:  D Valle; S I Goodman; D A Applegarth; V E Shih; J M Phang
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

10.  The risks of seizure disorders among relatives of patients with childhood onset epilepsy.

Authors:  J F Annegers; W A Hauser; V E Anderson; L T Kurland
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

View more
  27 in total

1.  Long-term proline exposure alters nucleotide catabolism and ectonucleotidase gene expression in zebrafish brain.

Authors:  Luiz Eduardo Baggio Savio; Fernanda Cenci Vuaden; Denis B Rosemberg; Maurício R Bogo; Carla Denise Bonan; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2012-06-07       Impact factor: 3.584

2.  Evidence that hyperprolinemia alters glutamatergic homeostasis in rat brain: neuroprotector effect of guanosine.

Authors:  Andréa G K Ferreira; Aline A da Cunha; Emilene B Scherer; Fernanda R Machado; Maira J da Cunha; Andressa Braga; Ben Hur Mussulini; Júlia D Moreira; Susana Wofchuk; Diogo O Souza; Angela T S Wyse
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

3.  Acute encephalopathy associated with influenza virus infection in a patient with hyperprolinaemia type II.

Authors:  Y Kato; K Ihara; K Miyako; T Kuhara; Y Inoue; T Hara
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Type II hyperprolinaemia with renal involvement.

Authors:  H Bellet; D Morin; H Daudet; M L Dumas; H Valette; B Magnan de Bornier; R Dumas
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

5.  Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia.

Authors:  Steffi van de Ven; Thatjana Gardeitchik; Dorus Kouwenberg; Leo Kluijtmans; Ron Wevers; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2013-10-31       Impact factor: 4.982

6.  Role of antioxidants on Na(+),K (+)-ATPase activity and gene expression in cerebral cortex of hyperprolinemic rats.

Authors:  Andréa G K Ferreira; Francieli M Stefanello; Aline A Cunha; Maira J da Cunha; Talita C B Pereira; Carla D Bonan; Maurício R Bogo; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2011-04-21       Impact factor: 3.584

7.  A Genetic Analysis of the Caenorhabditis elegans Detoxification Response.

Authors:  Tetsunari Fukushige; Harold E Smith; Johji Miwa; Michael W Krause; John A Hanover
Journal:  Genetics       Date:  2017-04-19       Impact factor: 4.562

8.  Proline impairs energy metabolism in cerebral cortex of young rats.

Authors:  Andréa G K Ferreira; Daniela D Lima; Débora Delwing; Vanize Mackedanz; Bárbara Tagliari; Janaína Kolling; Patrícia F Schuck; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2010-05-01       Impact factor: 3.584

Review 9.  New treatment paradigms in neonatal metabolic epilepsies.

Authors:  P L Pearl
Journal:  J Inherit Metab Dis       Date:  2009-02-24       Impact factor: 4.982

10.  Proline reduces creatine kinase activity in the brain cortex of rats.

Authors:  Adriana Kessler; Elisa Costabeber; Carlos Severo Dutra-Filho; Angela Terezinha Souza Wyse; Moacir Wajner; Clóvis Milton Duval Wannmacher
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.